Skip to main content
Caplight Logo









Notify Therapeutics

Notify Therapeutics

Private
CopenhagenHealthcare & Life Scienceshttps://www.notifytherapeutics.com/

Last Round

Seed

Sep 25, 2023

Total Funding Raised

$6.86M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Notify Therapeutics is a biotechnology company developing a first-in-class, non-hormonal fertility treatment for women with diminished ovarian reserve.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

fertility treatmentdiminished ovarian reserveDORnon-hormonal fertilitybiotechnologydrug discoveryreproductive medicineovarian follicle activationfertility techpreclinical biotechegg maturationfemtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Notify Therapeutics Comparables

Compare Notify Therapeutics with similar companies based on industry and business-model similarity.

Notify Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
U-Ploid Biotechnologies
75%
Granata Bio
74%
Celmatix
64%

Notify Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 25, 2023
SeedSep 23, 2021

Key People

Founding team and executive leadership

Karin Lykke-Hartmann

Chief Executive Officer

Executive Team

Notify Therapeutics Investors

Notable investors and investment history

Notify Therapeutics investors
InvestorRounds
Lundbeckfonden BioCapitalSeed
ND CapitalSeed
BioInnovation InstituteSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 19, 2026

    Monthly visitors increased 1081% MoM, reaching 2.6K.

Notify Therapeutics Filings

Explore SEC and related filing metadata, where available.

Notify Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Notify Therapeutics's valuation, stock price, and market status.

Is Notify Therapeutics a public or private company?

Notify Therapeutics is a private company.

What is the current stock price of Notify Therapeutics?

Notify Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Notify Therapeutics worth (valuation)?

Valuation information for Notify Therapeutics is not publicly available.

Can I buy Notify Therapeutics stock?

Notify Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Notify Therapeutics's last funding round?

Notify Therapeutics's most recent funding round was Seed on September 25, 2023.

Who are the main investors in Notify Therapeutics?

Key investors in Notify Therapeutics include Lundbeckfonden BioCapital, ND Capital, BioInnovation Institute.

Will Notify Therapeutics IPO soon?

No public IPO plans have been announced for Notify Therapeutics.

How can I track Notify Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Notify Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range7
Year Founded2021
Last FundingSep 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?